Extract
Acusphere Inc. Issues Letter to Shareholders.
LEXINGTON, Mass. -- Acusphere, Inc. (ACUS.PK) today issued the following letter to shareholders:
Dear Fellow Shareholders:We have been working diligently to support continued development of our lead product candidate, Imagify[TM] (Perflubutane Polymer Microspheres) for Injectable Suspension. We have now arrived at an important juncture, and we need your support to help effect a reverse stock split to allow the Company to finance the completion of our strategic direction.Imagify is under development as a cardiovascular drug intended for the detection of coronary artery disease (CAD), the leading cause of death in the U.S. It remains the leading development c...See the full content of this document
Sponsored links
